Ilic D, Neuberger MM, Djulbegovic M, Dahm P. Screening for prostate cancer. Cochrane Database Syst Rev. 2013;1:CD004720
Guía Clínica sobre Cáncer de Próstata. A Heidenreich , M Bolla, S Joniau, M.D. Mason, V. Matveev, N. Mottet, H-P. Schmid, T.H. van der Kwast, T. Wiegel, F. Zattoni. European Association of Urology 2010
Guía clínica sobre el cáncer de próstata. A. Heidenreich, M. Bolla, S. Joniau, M.D. Mason, V. Matveev, N. Mottet, H-P. Schmid, T.H. van der Kwast, T. Wiegel, F. Zattoni. European Association of Urology 2010
Chen YK, Kao CH, Liao AC, Shen YY, Su CT. Colorectal cancer screening in asymptomatic adults. The role of FDG PET scan. Anticancer Res 2003,23:4357-61.
Terauchi T, Murano T, Daisaki H, Kanou D, Shoda H, Kakinuma R et al. Evaluation of whole body cancer screening using 18F FDG PET: a preliminary report, Ann Nucl Med 2008;22:379-85.
Yasuda S, Ide M, Fujii H, Nakahara T, Mochizuki Y, Takahasni W et al. Application of positron emission tomography imaging to cancer screening. Br J Cancer 2000;83:1607-11.
Ravizza D, Bartolomei M, Santoro L, Tamayo D, Fiori G, Trovato C et al. Positron emission tomography for the detection of colorectal adenoma. Dig Liver Dis 2010;42:185-90.
. Gollub MJ, Grewal RK, Panu N et al. Diagnostic accuracy of 18F-FDG PET/CT for detection of advanced colorectal adenoma. Clin Radiol 2014; 69(6):611-8.